Omega Healthcare Investors, Inc. (NYSE:OHI) Receives $39.70 Consensus PT from Brokerages

Shares of Omega Healthcare Investors, Inc. (NYSE:OHI – Get Free Report) have been given an average recommendation of “Hold” by the twelve brokerages that are covering the company, MarketBeat reports. Seven research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month [...]

featured-image

Shares of Omega Healthcare Investors, Inc. ( NYSE:OHI – Get Free Report ) have been given an average recommendation of “Hold” by the twelve brokerages that are covering the company, MarketBeat reports. Seven research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company.

The average 12 month target price among analysts that have covered the stock in the last year is $40.00. Several equities analysts have recently weighed in on OHI shares.



Royal Bank of Canada raised their price objective on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a research report on Monday.

Berenberg Bank initiated coverage on shares of Omega Healthcare Investors in a report on Friday, October 18th. They set a “buy” rating and a $45.00 target price for the company.

Mizuho cut Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and upped their price target for the company from $34.00 to $35.00 in a report on Thursday, July 25th.

Scotiabank increased their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a research report on Monday, August 26th.

Finally, BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price on the stock in a report on Thursday, October 31st. Get Our Latest Analysis on Omega Healthcare Investors Omega Healthcare Investors Trading Up 0.

1 % Omega Healthcare Investors Dividend Announcement The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Monday, November 4th will be given a dividend of $0.67 per share.

The ex-dividend date is Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a yield of 6.

47%. Omega Healthcare Investors’s payout ratio is presently 197.06%.

Insider Transactions at Omega Healthcare Investors In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.

19, for a total value of $905,962.98. Following the transaction, the chief financial officer now owns 183,076 shares in the company, valued at approximately $7,357,824.

44. This represents a 0.00 % decrease in their position.

The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website . In other news, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction dated Friday, September 27th.

The stock was sold at an average price of $40.19, for a total transaction of $905,962.98.

Following the completion of the sale, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This trade represents a 0.

00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink . Also, COO Daniel J.

Booth sold 56,725 shares of the business’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.

25. Following the completion of the sale, the chief operating officer now directly owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. The trade was a 0.

00 % decrease in their position. The disclosure for this sale can be found here . 1.

37% of the stock is owned by insiders. Institutional Inflows and Outflows Hedge funds have recently modified their holdings of the business. Versant Capital Management Inc bought a new stake in Omega Healthcare Investors in the second quarter worth $26,000.

UMB Bank n.a. raised its holdings in Omega Healthcare Investors by 353.

4% during the third quarter. UMB Bank n.a.

now owns 662 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 516 shares in the last quarter. DiNuzzo Private Wealth Inc. acquired a new stake in shares of Omega Healthcare Investors in the third quarter worth about $33,000.

V Square Quantitative Management LLC boosted its stake in shares of Omega Healthcare Investors by 49.5% during the 3rd quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock worth $40,000 after acquiring an additional 323 shares in the last quarter.

Finally, Covestor Ltd boosted its stake in shares of Omega Healthcare Investors by 47.6% during the 1st quarter. Covestor Ltd now owns 1,337 shares of the real estate investment trust’s stock worth $42,000 after acquiring an additional 431 shares in the last quarter.

Institutional investors and hedge funds own 65.25% of the company’s stock. About Omega Healthcare Investors ( Get Free Report Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities.

Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S.

, as well as in the U.K. Featured Articles Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.

com's FREE daily email newsletter ..